Challenges Assessing Clinical Endpoints in Early Huntington Disease

Movement Disorders - United States
doi 10.1002/mds.23337
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Wiley

Related search

Exploring Novel Endpoints for Clinical Trials in Kidney Disease: Challenges and Opportunities

Kidney International Reports
Nephrology
2017English

Fourth Annual Huntington Disease Clinical Research Symposium

Neurotherapeutics
NeurologyPharmacology
2010English

Fifth Annual Huntington Disease Clinical Research Symposium

Neurotherapeutics
NeurologyPharmacology
2012English

Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease

JAMA Neurology
Neurology
2017English

Methodological Challenges in Assessing the Impact of Comorbidities on Costs in Alzheimer’s Disease Clinical Trials

European Journal of Health Economics
Health PolicyEconomicsEconometricsFinance
2014English

Clinical Recommendations to Guide Physical Therapy Practice for Huntington Disease

Neurology
Neurology
2020English

Randomized Controlled Trial of Atomoxetine for Cognitive Dysfunction in Early Huntington Disease

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2009English

Movement Sequencing in Huntington Disease

World Journal of Biological Psychiatry
MedicinePsychiatryMental HealthBiological Psychiatry
2014English

Body Weight Is a Robust Predictor of Clinical Progression in Huntington Disease

Annals of Neurology
Neurology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy